Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:48 UTC |
Jacroux RichardChief Financial Officer
|
GrantCommon Stock | 13,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092251 · ownership.xml · nonDerivative · entry 1 Jacroux Richard · CIK 0002033818 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,461 F1 · security: Holdings include unvested restricted stock units ("RSUs"). F2 · shares: Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. F1 · balance_after: Holdings include unvested restricted stock units ("RSUs"). Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:48 UTC |
Tokman Alexander YDirector · Chief Executive Officer
|
GrantCommon Stock | 26,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092253 · ownership.xml · nonDerivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,926 F1 · security: Holdings include unvested restricted stock units ("RSUs"). F2 · shares: Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. F1 · balance_after: Holdings include unvested restricted stock units ("RSUs"). Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 00:44 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantCommon Stock | 60,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021415 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,589 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 19:43 UTC |
Jacroux RichardChief Financial Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021413 · ownership.xml · nonDerivative · entry 1 Jacroux Richard · CIK 0002033818 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 00:43 UTC |
Basenese LouDirector
|
GrantCommon Stock | 60,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021412 · ownership.xml · nonDerivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,709 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 19:42 UTC |
Tokman Alexander YDirector · Chief Executive Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021411 · ownership.xml · nonDerivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,005 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027. Read SEC document |
| January 21, 2026 Filed Jan 24, 2026 00:43 UTC |
Harsh MichaelDirector
|
GrantCommon Stock | 60,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021414 · ownership.xml · nonDerivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,710 F1 · security: Holdings include unvested restricted stock units ("RSUs"). F2 · shares: Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2026. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:54 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantWarrants · Derivative | 141,644 | $7.06 Strike: $6.81 | $1,000,006.64 |
DisclosureSEC source: 0001193125-25-240662 · ownership.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,644 Underlying: Common Stock · 141,644 shares Expires 2030-10-15 F1 · kind: The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:54 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantCommon Stock | 70,822 | $7.06 | $500,003.32 |
DisclosureSEC source: 0001193125-25-240662 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,265 F1 · kind: The shares of Common Stock and Warrants were purchased from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: Each share of Common Stock was purchased together with Warrants exercisable for two shares of Common Stock. F3 · balance_after: Includes unvested restricted stock units. Read SEC document |
| June 11, 2025 Filed Jul 1, 2025 10:25 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantCommon Stock | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091885 · ownership.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,443 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jul 1, 2025 10:26 UTC |
Basenese LouDirector
|
GrantCommon Stock | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091888 · ownership.xml · nonDerivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,385 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. Read SEC document |
| June 11, 2025 Filed Jul 1, 2025 10:25 UTC |
Harsh MichaelDirector
|
GrantCommon Stock | 5,384 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-091887 · ownership.xml · nonDerivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,386 F1 · shares: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 20:30 UTC |
UBS Group AG10% owner
|
PurchaseCommon Stock | 3,715 | $0.55 | $2,051.79 |
DisclosureSEC source: 0001610520-24-000151 · primary_doc.xml · nonDerivative · entry 1 UBS Group AG · CIK 0001610520 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Subsidiary Disclosed balance after: 146,012 F1 · ownership.nature: This Statement is filed jointly by UBS Group AG for the benefit and on behalf of UBS Securities LLC and UBS Financial Services Inc., a wholly owned subsidiary of UBS Group Read SEC document |
| August 27, 2024 Filed Sep 5, 2024 19:28 UTC Amendment |
UBS Group AGMarket maker/broker-dealer
|
PurchaseCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001610520-24-000153 · primary_doc.xml · nonDerivative · entry 1 UBS Group AG · CIK 0001610520 · Market maker/broker-dealer 10b5-1 filing: No plan indicated Ownership: Indirect · By Subsidiary Disclosed balance after: 146,012 F1 · ownership.nature: This Statement is filed jointly by UBS Group AG for the benefit and on behalf of UBS Securities LLC and UBS Financial Services Inc., a wholly owned subsidiary of UBS Group. F2 · ownership.nature: This Form 4 Amendment is being filed to correct and replace the original Form 4 filed on August 29, 2024. Subsequent to the date of first filing, the Reporting Person confirmed directly with the Issuer that, due to certain warrant exercises effected on August 27, 2024, the total outstanding common shares issued by ENDRA Life Sciences as of August 27, 2024 was 16,932,593 shares. When taking the revised share count into consideration, the Reporting Person determined it never beneficially owned more than 10% of ENDRA shares. Therefore the Form 4 previously filed by the Reporting Person was erroneous and unnecessary Read SEC document |
| January 02, 2024 Filed Feb 23, 2024 22:00 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantStock Options · Derivative | 600 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-24-003901 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2034-01-02 F1 · shares: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025. Read SEC document |
| January 02, 2024 Filed Feb 23, 2024 22:00 UTC |
Basenese LouDirector
|
GrantStock Options · Derivative | 600 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-24-003899 · doc4.xml · derivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2034-01-02 F1 · shares: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025. Read SEC document |
| January 02, 2024 Filed Feb 23, 2024 17:00 UTC |
Tokman Alexander YDirector
|
GrantStock Options · Derivative | 600 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-24-003902 · doc4.xml · derivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2034-01-02 F1 · shares: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025. Read SEC document |
| January 02, 2024 Filed Feb 23, 2024 22:00 UTC |
Harsh MichaelDirector
|
GrantStock Options · Derivative | 600 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001209191-24-003900 · doc4.xml · derivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2034-01-02 F1 · shares: Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025. Read SEC document |
| May 18, 2023 Filed May 22, 2023 11:30 UTC |
Thornton Michael MilosChief Technology Officer
|
PurchaseCommon Stock | 15,000 | $1.65 | $24,750.00 |
DisclosureSEC source: 0001209191-23-031298 · doc4.xml · nonDerivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,139 Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:07 UTC |
DIGIANDOMENICO ANTHONYDirector
|
PurchaseWarrants · Derivative | 41,667 | $0.01 Strike: $1.40 | $416.67 |
DisclosureSEC source: 0001209191-23-026925 · doc4.xml · derivative · entry 2 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Stock · 41,667 shares Expires 2028-05-02 F2 · price: The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering. F3 · derivative.underlying_shares: Represents warrants purchased in the Offering. The warrants were offered and sold at the rate of one warrant to purchase one share for every two shares of common stock purchased in the Offering. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:07 UTC |
DIGIANDOMENICO ANTHONYDirector
|
PurchaseCommon Stock | 83,333 | $1.20 | $99,999.60 |
DisclosureSEC source: 0001209191-23-026925 · doc4.xml · nonDerivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,434 F1 · shares: Represents shares purchased in the Registrant's underwritten public offering that closed May 2, 2023 (the "Offering"). F2 · price: The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $2.41 per set of securities, yielding an effective price of $1.20 per share and $0.01 per warrant in the Offering. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantStock Options · Derivative | 9,621 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006049 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,621 Underlying: Common Stock · 9,621 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC |
Basenese LouDirector
|
GrantStock Options · Derivative | 6,746 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006052 · doc4.xml · derivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,746 Underlying: Common Stock · 6,746 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:30 UTC |
Michelon Francois RogerDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 69,531 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006046 · doc4.xml · derivative · entry 1 Michelon Francois Roger · CIK 0001691470 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,531 Underlying: Common Stock · 69,531 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:30 UTC |
Tokman Alexander YDirector
|
GrantStock Options · Derivative | 9,621 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006051 · doc4.xml · derivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,621 Underlying: Common Stock · 9,621 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC |
Harsh MichaelDirector
|
GrantStock Options · Derivative | 9,634 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006050 · doc4.xml · derivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,634 Underlying: Common Stock · 9,634 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC |
Pestrikova IrinaSenior Director, Finance
|
GrantStock Options · Derivative | 8,000 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006048 · doc4.xml · derivative · entry 1 Pestrikova Irina · CIK 0001868216 · Senior Director, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 2, 2023 01:30 UTC |
Thornton Michael MilosChief Technology Officer
|
GrantStock Options · Derivative | 68,066 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-23-006047 · doc4.xml · derivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,066 Underlying: Common Stock · 68,066 shares Expires 2033-01-30 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 21:00 UTC |
Thornton Michael MilosChief Technology Officer
|
PurchaseCommon Stock | 1,500 | $3.40 | $5,100.00 |
DisclosureSEC source: 0001209191-22-060895 · doc4.xml · nonDerivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,139 F1 · balance_after: On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the "Reverse Stock Split") of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| November 23, 2022 Filed Nov 28, 2022 17:00 UTC |
Tokman Alexander YDirector
|
PurchaseCommon Stock | 10,000 | $0.17 | $1,700.00 |
DisclosureSEC source: 0001209191-22-058875 · doc4.xml · nonDerivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,857 Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 08:55 UTC |
Tokman Alexander YDirector
|
PurchaseCommon Stock | 20,000 | $0.26 | $5,200.00 |
DisclosureSEC source: 0001209191-22-047297 · doc4.xml · nonDerivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,857 Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 12:57 UTC |
Thornton Michael MilosChief Technology Officer
|
PurchaseCommon Stock | 20,000 | $0.27 | $5,400.00 |
DisclosureSEC source: 0001209191-22-047298 · doc4.xml · nonDerivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,775 Read SEC document |
| May 26, 2022 Filed May 31, 2022 12:46 UTC |
Thornton Michael MilosChief Technology Officer
|
PurchaseCommon Stock | 25,000 | $0.21 | $5,250.00 |
DisclosureSEC source: 0001209191-22-032746 · doc4.xml · nonDerivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,775 Read SEC document |
| May 18, 2022 Filed May 23, 2022 20:30 UTC |
Thornton Michael MilosChief Technology Officer
|
PurchaseCommon Stock | 25,000 | $0.22 | $5,500.00 |
DisclosureSEC source: 0001209191-22-031319 · doc4.xml · nonDerivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,775 Read SEC document |
| May 17, 2022 Filed May 19, 2022 07:00 UTC |
Michelon Francois RogerDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,100 | $0.19 | $969.00 |
DisclosureSEC source: 0001209191-22-030307 · doc4.xml · nonDerivative · entry 1 Michelon Francois Roger · CIK 0001691470 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,191 Read SEC document |
| May 16, 2022 Filed May 17, 2022 16:14 UTC |
Tokman Alexander YDirector
|
PurchaseCommon Stock | 100,000 | $0.20 | $19,630.00 |
DisclosureSEC source: 0001209191-22-029593 · doc4.xml · nonDerivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,857 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1911 to $0.1963, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantStock Options · Derivative | 109,323 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021621 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,323 Underlying: Common Stock · 109,323 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC |
Basenese LouDirector
|
GrantStock Options · Derivative | 74,500 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021618 · doc4.xml · derivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,500 Underlying: Common Stock · 74,500 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 17:15 UTC |
Michelon Francois RogerDirector · Chief Executive Officer
|
GrantStock Options · Derivative | 713,132 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021622 · doc4.xml · derivative · entry 1 Michelon Francois Roger · CIK 0001691470 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,132 Underlying: Common Stock · 713,132 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 17:15 UTC |
Tokman Alexander YDirector
|
GrantStock Options · Derivative | 109,323 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021623 · doc4.xml · derivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,323 Underlying: Common Stock · 109,323 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:16 UTC |
Maloberti Renaud BertrandChief Commercial Officer
|
GrantStock Options · Derivative | 186,430 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021625 · doc4.xml · derivative · entry 1 Maloberti Renaud Bertrand · CIK 0001744025 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,430 Underlying: Common Stock · 186,430 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC |
Thornton Michael MilosChief Technology Officer
|
GrantStock Options · Derivative | 698,102 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021624 · doc4.xml · derivative · entry 1 Thornton Michael Milos · CIK 0001706297 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,102 Underlying: Common Stock · 698,102 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC |
Pestrikova IrinaSenior Director, Finance
|
GrantStock Options · Derivative | 41,500 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021620 · doc4.xml · derivative · entry 1 Pestrikova Irina · CIK 0001868216 · Senior Director, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 41,500 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:15 UTC |
Harsh MichaelDirector
|
GrantStock Options · Derivative | 109,492 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001209191-22-021619 · doc4.xml · derivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,492 Underlying: Common Stock · 109,492 shares Expires 2032-03-28 F1 · derivative.exercise_date: This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:06 UTC |
DIGIANDOMENICO ANTHONYDirector
|
GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-000957 · doc4.xml · derivative · entry 1 DIGIANDOMENICO ANTHONY · CIK 0001083544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:03 UTC |
Basenese LouDirector
|
GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-000951 · doc4.xml · derivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 17:07 UTC |
Tokman Alexander YDirector
|
GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-000961 · doc4.xml · derivative · entry 1 Tokman Alexander Y · CIK 0001334483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:05 UTC |
Harsh MichaelDirector
|
GrantStock Options · Derivative | 12,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-000954 · doc4.xml · derivative · entry 1 Harsh Michael · CIK 0001706155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-01-03 F1 · shares: Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:15 UTC |
Basenese LouDirector
|
SaleCommon Stock | 5,000 | $1.85 | $9,250.00 |
DisclosureSEC source: 0001209191-21-053613 · doc4.xml · nonDerivative · entry 2 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,068 Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 20:15 UTC |
Basenese LouDirector
|
SaleCommon Stock | 45,000 | $1.83 | $82,350.00 |
DisclosureSEC source: 0001209191-21-053613 · doc4.xml · nonDerivative · entry 1 Basenese Lou · CIK 0001809482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,068 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $1.84, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.